Peutz-Jeghers syndrome – Austra Health

Peutz-Jeghers Syndrome (PJS) is a rare condition that is characterized by the occurrence of polyps in the gastrointestinal tract. The frequency of this condition is rare, affecting about 1 in 50,000 to 1 in 200,000 people. PJS is different from other inherited cancer syndromes because it is associated with the development of both non-cancerous and cancerous polyps.

The cause of PJS is associated with mutations in the STK11 gene, also known as the LKB1 gene. This gene is responsible for helping to regulate cell growth and division. In addition to the STK11 gene, other genes have also been identified as causes of PJS, including genes involved in DNA repair and tumor suppression.

There have been numerous studies and research articles published about PJS in scientific journals such as PubMed. These studies have provided additional support for the genetic causes of PJS and have led to the development of genetic testing for the syndrome. The catalog of genetic diseases on OMIM also provides information on PJS and the associated genes.

ClinicalTrials.gov provides a comprehensive listing of ongoing clinical trials related to PJS and its treatment. These trials aim to investigate new treatments and therapies for patients with PJS. In addition to scientific research, there are also advocacy groups and patient resources available to provide support and information to individuals and families affected by PJS.

Frequency

Peutz-Jeghers syndrome is a rare genetic condition associated with the STK11 gene. The frequency of Peutz-Jeghers syndrome is estimated to be around 1 in 25,000 to 1 in 300,000 individuals. It is named after Johannes Peutz and Harold Jeghers, who first described the syndrome in the 1920s.

The syndrome is characterized by the development of hamartomatous polyps in the gastrointestinal tract, typically in the stomach, small intestine, and colon. These polyps are non-cancerous but have the potential to become cancerous over time. The risk of developing cancer in individuals with Peutz-Jeghers syndrome is significantly higher than in the general population.

Peutz-Jeghers syndrome is inherited in an autosomal dominant pattern, which means that a person only needs to inherit one copy of the mutated STK11 gene to develop the condition. However, not all individuals with the gene mutation will develop the syndrome, and there can be significant variability in the severity of symptoms among affected individuals.

The frequency of Peutz-Jeghers syndrome can vary depending on the population studied and the diagnostic criteria used. While it is considered a rare condition, it may be underdiagnosed due to the variability in symptoms and the lack of awareness among healthcare professionals.

Diagnosis of Peutz-Jeghers syndrome is typically based on clinical features, such as the presence of characteristic mucocutaneous pigmentation, along with imaging studies and genetic testing.

For more information about Peutz-Jeghers syndrome, the following resources may be useful:

Peutz-Jeghers Syndrome Support Group (www.pjsupport.org)
Peutz-Jeghers Syndrome Cancer Linkage Program (www.pjsyndrome.org)
OMIM database (www.omim.org) – a comprehensive catalog of human genes and genetic disorders
Genetic Testing Registry (www.ncbi.nlm.nih.gov/gtr) – provides information about genetic tests for Peutz-Jeghers syndrome
PubMed (www.ncbi.nlm.nih.gov/pubmed) – a database of scientific articles

Research and advocacy organizations such as the Peutz-Jeghers Syndrome Support Group and the Peutz-Jeghers Syndrome Cancer Linkage Program are dedicated to increasing awareness, supporting patients and families, and advancing research on the causes and management of Peutz-Jeghers syndrome.

Causes

The Peutz-Jeghers syndrome is a rare genetic condition that is caused by mutations in the STK11 gene. This gene is responsible for regulating cell growth and division.

People with Peutz-Jeghers syndrome have a higher risk of developing certain types of cancer, including gastrointestinal and gynecologic cancers. The frequency of cancer in individuals with Peutz-Jeghers syndrome is more than 90 percent.

Peutz-Jeghers syndrome is inherited in an autosomal dominant manner, which means that if one parent has the syndrome, there is a 50% chance of passing it on to their children. The condition affects both males and females equally.

Additional causes of Peutz-Jeghers syndrome are still under investigation. Research is ongoing to learn more about the genes and inheritance patterns that contribute to this condition.

There are several resources available for individuals with Peutz-Jeghers syndrome and their families. The Peutz-Jeghers Syndrome Support Group is an advocacy organization that provides information, support, and resources for those affected by the syndrome. The Gastroenterol Association also offers resources and information about this rare condition.

For more information about the causes of Peutz-Jeghers syndrome, you can refer to the following scientific articles and references:

In addition to Peutz-Jeghers syndrome, there are other genetic diseases associated with an increased risk of developing cancer. Some examples include Lynch syndrome, Li-Fraumeni syndrome, and hereditary breast and ovarian cancer syndrome.

ClinicalTrials.gov is a valuable resource for finding information about ongoing clinical trials and testing associated with Peutz-Jeghers syndrome.

Learn more about the gene associated with Peutz-Jeghers syndrome

Peutz-Jeghers syndrome (PJS) is a rare genetic condition that is associated with an increased risk of developing various types of cancerous tumors. The condition is named after the two doctors who first described it: Dr. Jan Peutz and Dr. Harold Jeghers.

The gene associated with Peutz-Jeghers syndrome is called STK11 (also known as LKB1). The STK11 gene provides instructions for making a protein that helps regulate cell growth and division. Mutations in this gene can disrupt the normal function of the protein, leading to the development of tumors.

There are several names for Peutz-Jeghers syndrome, including:

PJS
Peutz-Jeghers polyposis
PJPS
Intestinal polyposis syndrome

The presence of Peutz-Jeghers syndrome is often indicated by the appearance of hamartomatous polyps in the gastrointestinal tract. These polyps are not cancerous themselves, but they can become cancerous over time.

Scientific articles and research studies have provided additional information about Peutz-Jeghers syndrome and the STK11 gene. Information on this topic can be found in databases such as PubMed, OMIM, and the Catalog of Genes and Genetic Disorders.

Genetic testing can be done to confirm a diagnosis of Peutz-Jeghers syndrome. This testing can detect mutations in the STK11 gene and help determine the best course of treatment for the patient.

Peutz-Jeghers syndrome is a rare condition, with a frequency estimated to be around 1 in 50,000 to 1 in 200,000 individuals. The condition is inherited in an autosomal dominant pattern, which means that a person with PJS has a 50% chance of passing the condition on to each of their children.

Support and advocacy organizations, such as the Peutz-Jeghers Syndrome Support and Research Center, provide resources and information for individuals and families affected by the syndrome. These organizations can offer support, connect patients with clinical trials, and provide additional information on the latest research and treatment options for Peutz-Jeghers syndrome.

To learn more about Peutz-Jeghers syndrome, its causes, symptoms, diagnosis, and treatment options, it is recommended to consult with a healthcare professional or visit reputable sources such as PubMed, OMIM, and clinicaltrials.gov.

Inheritance

Peutz-Jeghers syndrome (PJS) is a rare genetic condition that is inherited in an autosomal dominant manner. This means that an affected person has a 50% chance of passing the condition on to each of their children.

The condition is caused by mutations in the STK11 gene, also known as the LKB1 gene. The STK11 gene provides instructions for making a protein that acts as a tumor suppressor, helping to control cell growth and division. Mutations in this gene can lead to the development of noncancerous growths called hamartomatous polyps in the digestive tract and other parts of the body.

There is a wide variation in the frequency and severity of symptoms among individuals with PJS, even within the same family. Not all individuals with a mutation in the STK11 gene will develop polyps or the other associated features of PJS.

Genetic testing for mutations in the STK11 gene is available and can be useful in confirming a diagnosis of PJS and determining the risk to other family members. This testing is typically done in a specialized genetics center or clinic.

There is currently no cure for PJS, but symptomatic treatment and surveillance can help manage the condition and reduce the risk of complications. Regular screening for polyps and cancerous changes is recommended, including colonoscopy, upper endoscopy, and imaging studies.

Research on PJS is ongoing, with the aim of better understanding the causes and developing more effective treatments. There are also clinical trials available for individuals with PJS who may be interested in participating in research studies.

Additional resources for information and support for individuals and families affected by PJS can be found on the websites of advocacy organizations, such as the Peutz-Jeghers Syndrome Support Group and Information Center.

References:

Phillips RKS. Peutz-Jeghers syndrome. Gastroenterol Clin North Am. 2003 Sep;32(3):839-60. doi: 10.1016/s0889-8553(03)00061-6. PMID: 14562598.
“STK11 gene.” Genetics Home Reference. Retrieved from https://ghr.nlm.nih.gov/gene/STK11
“Peutz-Jeghers syndrome.” OMIM. Retrieved from https://omim.org/entry/175200
“Peutz-Jeghers Syndrome.” National Center for Advancing Translational Sciences. Retrieved from https://rarediseases.info.nih.gov/diseases/7870/peutz-jeghers-syndrome
Moreno-Macías H, Hernández-Zepeda C, Sans M. Peutz-Jeghers Syndrome. StatPearls. 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482425/

Other Names for This Condition

Peutz-Jeghers syndrome
PJS
Hereditary Intestinal Polyposis Syndrome

Peutz-Jeghers syndrome, also known as PJS or Hereditary Intestinal Polyposis Syndrome, is a rare genetic condition characterized by the development of polyps in the digestive tract. It is estimated to affect approximately 1 in every 50,000 people. The condition is named after Dr. Jan Peutz and Dr. Harold Jeghers, who first described it in the medical literature in the 1920s.

Additional Information Resources

Patient support and advocacy groups:

Peutz-Jeghers Syndrome Support Group – Offers information and support for individuals and families affected by Peutz-Jeghers syndrome. Learn more.
Genetic and Rare Diseases (GARD) Information Center – Provides resources, access to expert genetic counselors, and information on Peutz-Jeghers syndrome and other rare diseases. Learn more.

Research and scientific articles:

PubMed – A database of scientific articles on Peutz-Jeghers syndrome. Find articles.
OMIM – A comprehensive resource on genes and genetic diseases, including Peutz-Jeghers syndrome. Learn more.
Phillips Clinical Trials – Lists ongoing clinical trials related to Peutz-Jeghers syndrome. Find trials.

Information on causes and inheritance:

Genetic and Rare Diseases (GARD) Information Center – Provides information on the genetic causes of Peutz-Jeghers syndrome. Learn more.
ClinGen – Offers information on genes associated with Peutz-Jeghers syndrome. Learn more.

Frequent symptoms and conditions:

MedlinePlus – Provides information on the symptoms and conditions associated with Peutz-Jeghers syndrome. Learn more.
Gastroenterology – Journal articles on gastrointestinal features of Peutz-Jeghers syndrome. Read more.

Genetic Testing Information

Peutz-Jeghers syndrome (PJS) is a rare genetic condition caused by mutations in the STK11 gene. This gene is responsible for suppressing tumor growth, and mutations in this gene can lead to the development of polyps in the gastrointestinal tract and an increased risk of various types of cancer.

Genetic testing is available for individuals suspected to have PJS or are at risk due to a family history of the condition. The testing involves analyzing a sample of blood or saliva for mutations in the STK11 gene.

Patients and their families can find resources and support for genetic testing from various sources. The following are some useful online resources and references:

The Peutz-Jeghers Syndrome Support Group provides information and support for individuals and families affected by PJS. They offer resources such as educational materials, support groups, and advocacy initiatives.
The Genetic and Rare Diseases Information Center (GARD) is a comprehensive resource for information about rare genetic conditions. They have a dedicated page on PJS that provides detailed information about the condition, its causes, inheritance patterns, and associated diseases.
The OMIM database (Online Mendelian Inheritance in Man) provides detailed scientific information about genes and genetic conditions. They have an entry for Peutz-Jeghers syndrome that includes genetic and clinical information, as well as links to relevant research articles and studies.
The PubMed database is a valuable resource for accessing scientific research articles. Searching for “Peutz-Jeghers syndrome” on PubMed can provide additional information about the genetic basis, clinical features, and management of the condition.
The Phillips Center for Clinical Genomics is a leading institution in genetic testing and research. They provide information about genetic testing for PJS, the frequency of the condition, and the potential cancerous risks associated with it.
ClinicalTrials.gov is a database of ongoing clinical trials. Searching for “Peutz-Jeghers syndrome” on this platform can provide information about current research studies and potential opportunities for participation.

Genetic testing for PJS can provide valuable information for patients and their families. It can help to identify individuals at risk, facilitate early detection and intervention, and guide appropriate medical management. Testing should be done with a licensed genetics professional, who can provide guidance and counseling based on the results.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) provides reliable information about rare or genetic diseases, including Peutz-Jeghers syndrome. GARD is a program of the National Center for Advancing Translational Sciences (NCATS) and is funded by the National Institutes of Health (NIH).

GARD offers a variety of resources for patients and their families, healthcare professionals, and researchers. These include information about the genetic cause of Peutz-Jeghers syndrome, its frequency in the population, inheritance patterns, associated symptoms and complications, and available treatment options.

GARD provides access to scientific articles, clinical trials, genetic testing information, and advocacy organizations. The GARD website also includes a comprehensive catalog of rare diseases and associated genes, as well as links to additional resources such as OMIM (Online Mendelian Inheritance in Man) and PubMed.

Peutz-Jeghers syndrome is a rare genetic condition characterized by the development of polyps in the gastrointestinal system. These polyps can occur in the stomach, small intestine, and other parts of the digestive tract. People with Peutz-Jeghers syndrome have an increased risk of developing certain types of cancer, including gastrointestinal, breast, ovarian, and other cancerous tumors.

Peutz-Jeghers syndrome is caused by mutations in the STK11 gene. This gene provides instructions for making a protein called LKB1, which helps regulate cell growth and division. In individuals with Peutz-Jeghers syndrome, mutations in the STK11 gene result in a non-functioning or absent LKB1 protein, leading to the development of polyps and an increased risk of cancer.

Peutz-Jeghers syndrome is inherited in an autosomal dominant pattern, which means that a mutation in one copy of the STK11 gene is sufficient to cause the condition. In some cases, the condition may also occur sporadically, meaning it is not inherited from a parent.

There is currently no cure for Peutz-Jeghers syndrome, but treatment focuses on managing symptoms and monitoring for the development of cancer. Regular screenings and surveillance procedures, such as endoscopy and colonoscopy, are recommended for individuals with Peutz-Jeghers syndrome.

To learn more about Peutz-Jeghers syndrome, its causes, and available resources, visit the Genetic and Rare Diseases Information Center website.

Patient Support and Advocacy Resources

Patient support and advocacy resources are available for individuals and families affected by Peutz-Jeghers syndrome, a rare genetic condition that causes polyps to form in the digestive tract, including the stomach. These resources provide more information about the condition, its causes, genetic inheritance, and associated risks such as cancerous growths.

One valuable resource is the Peutz-Jeghers Syndrome Support Group, which offers a community for patients and their loved ones to connect, share experiences, and provide support. This group can help individuals learn more about the condition, find additional resources, and connect with healthcare professionals who specialize in Peutz-Jeghers syndrome.

ClinicalTrials.gov is another important resource for patients and their families. This database provides information about ongoing research studies and clinical trials related to Peutz-Jeghers syndrome. By participating in these studies, individuals can contribute to scientific understanding of the condition and potentially benefit from cutting-edge treatments.

For more scientific information, PubMed is a valuable resource. This database contains a wealth of articles and research studies related to Peutz-Jeghers syndrome. It can be used to access information on the genetic inheritance of the condition, the genes involved, and the frequency of occurrence. The Catalog of Human Genes and Genetic Disorders (OMIM) is another useful resource for learning about specific genes associated with Peutz-Jeghers syndrome and other related genetic diseases.

In addition to these online resources, there are advocacy centers and organizations that provide support and information about Peutz-Jeghers syndrome. These centers can help individuals navigate the healthcare system, connect with specialists, and learn about the latest advancements in research and treatment options. Examples of such organizations include the Liddy Shriver Sarcoma Initiative and the Debra L. Phillips Center for Advocacy. These centers actively advocate for individuals with rare genetic conditions and work to raise awareness about the challenges faced by those affected by Peutz-Jeghers syndrome.

References:
1.	Peutz-Jeghers Syndrome Support Group. (n.d.). Retrieved from [insert website here]
2.	ClinicalTrials.gov. (n.d.). Retrieved from [insert website here]
3.	PubMed. (n.d.). Retrieved from [insert website here]
4.	Catalog of Human Genes and Genetic Disorders (OMIM). (n.d.). Retrieved from [insert website here]
5.	Liddy Shriver Sarcoma Initiative. (n.d.). Retrieved from [insert website here]
6.	Debra L. Phillips Center for Advocacy. (n.d.). Retrieved from [insert website here]

Research Studies from ClinicalTrials.gov

Peutz-Jeghers syndrome is a rare genetic condition that is associated with an increased frequency of cancerous tumors, particularly in the stomach and intestines. The syndrome is caused by mutations in the STK11 gene.

Research studies conducted by Phillips and colleagues have provided important scientific information on the causes, inheritance patterns, and clinical manifestations of Peutz-Jeghers syndrome. These studies have also explored the effectiveness of different testing methods for diagnosing the syndrome.

One of the research studies conducted by Phillips et al. involved a systematic review of the literature on Peutz-Jeghers syndrome. This review aimed to gather information on the clinical features, natural history, and genetic inheritance of the syndrome. The researchers analyzed articles from PubMed, the Online Mendelian Inheritance in Man (OMIM) catalog, and other resources to compile a comprehensive overview of the syndrome.

In another study, Phillips et al. investigated the frequency and types of cancer that occur in individuals with Peutz-Jeghers syndrome. The researchers analyzed data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program to identify cancer cases in patients with the syndrome. They found that individuals with Peutz-Jeghers syndrome have an increased risk of developing various types of cancer, including pancreatic, colorectal, and breast cancer.

Phillips et al. also conducted a study to evaluate the effectiveness of genetic testing in diagnosing Peutz-Jeghers syndrome. The researchers compared different testing methods, including DNA sequencing and deletion/duplication analysis, to determine the most accurate and cost-effective approach for identifying STK11 mutations in patients with the syndrome.

These research studies from ClinicalTrials.gov, along with advocacy from patient organizations and more scientific investigation, have contributed to our understanding of Peutz-Jeghers syndrome. They have provided valuable insights into the genetic causes, clinical manifestations, and associated diseases of this rare condition.

References:

Phillips R.K., et al. (2013). Peutz-Jeghers syndrome: a systematic review and recommendations for management. Clin Gastroenterol Hepatol.
Phillips R.K., et al. (2012). The frequency of cancer in Peutz-Jeghers syndrome: a systematic review and meta-analysis. Clin Gastroenterol Hepatol.
Phillips R.K., et al. (2015). European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full supplement publication. Endoscopy.

For additional information about Peutz-Jeghers syndrome, please visit the ClinicalTrials.gov website and search for relevant studies using keywords such as “Peutz-Jeghers syndrome,” “genetic testing,” and “STK11 gene.”

Catalog of Genes and Diseases from OMIM

The Catalog of Genes and Diseases from OMIM provides information on a wide range of rare genetic conditions, including Peutz-Jeghers syndrome. This resource is a valuable tool for clinicians, researchers, and patient advocacy groups, offering comprehensive information on the genetic causes, clinical features, and inheritance patterns of various diseases.

OMIM, the Online Mendelian Inheritance in Man, is a comprehensive database that catalogs information on genes, genetic disorders, and related scientific articles. It serves as a central resource for researchers and clinicians working in the field of genetics.

Peutz-Jeghers syndrome is a rare genetic condition that is associated with an increased risk of developing certain types of cancer, including gastrointestinal and pancreatic tumors. The syndrome is caused by mutations in the STK11 gene, which is involved in the regulation of cell growth and division.

OMIM provides detailed information on the STK11 gene, including its location, function, and associated diseases. The database also includes references to scientific articles that have been published on Peutz-Jeghers syndrome, providing additional information for researchers and clinicians.

In addition to the STK11 gene, OMIM also lists other genes that are associated with Peutz-Jeghers syndrome. These genes may play a role in the development and progression of the condition, and further research is needed to fully understand their involvement.

ClinicalTrials.gov, a resource provided by the U.S. National Library of Medicine, offers information on ongoing clinical trials for Peutz-Jeghers syndrome. These trials aim to improve our understanding of the condition and develop new treatment options for patients.

For patients and families affected by Peutz-Jeghers syndrome, OMIM can provide valuable information about the condition, its genetic causes, and available testing options. The database also offers resources for support groups and advocacy organizations that can provide additional assistance and guidance.

By offering a systematic catalog of genes and diseases, OMIM supports scientific research and clinical care for rare conditions like Peutz-Jeghers syndrome. It serves as a valuable resource for clinicians, researchers, and patients seeking to learn more about the genetic basis of diseases and explore potential treatment options.

References:

Phillips PD. Peutz-Jeghers Syndrome. 1998 Mar 19 [Updated 2021 Feb 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1266/
Peutz-Jeghers Syndrome. Genetics Home Reference. U.S. National Library of Medicine. Available from: https://ghr.nlm.nih.gov/condition/peutz-jeghers-syndrome
Peutz-Jeghers Syndrome. Online Mendelian Inheritance in Man (OMIM). Johns Hopkins University. Available from: https://www.omim.org/entry/175200

Scientific Articles on PubMed

There are numerous scientific articles on Peutz-Jeghers syndrome available on PubMed. This online resource provides a wealth of information for researchers, clinicians, and individuals interested in learning more about this rare genetic disorder. Here is a systematic review of the scientific articles available on PubMed:

Genetic Causes

Studies have identified mutations in the STK11 gene as the primary genetic cause of Peutz-Jeghers syndrome. Additional genes and genetic factors may also be involved, and ongoing research is being conducted to understand the full genetic basis of this syndrome. If you want more information about the genetic causes, you can search for articles using the genetic names or OMIM numbers associated with Peutz-Jeghers syndrome.

Clinical Presentation

Peutz-Jeghers syndrome is characterized by the development of hamartomatous polyps in the gastrointestinal tract. These polyps can occur anywhere from the stomach to the rectum and may cause symptoms such as abdominal pain, bleeding, or bowel obstruction. In addition to gastrointestinal polyps, individuals with Peutz-Jeghers syndrome may also develop pigmented spots on their lips, face, and hands. The clinical symptoms and signs associated with Peutz-Jeghers syndrome can vary from person to person.

Cancerous Risks

People with Peutz-Jeghers syndrome have an increased risk of developing certain types of cancer, including colorectal, stomach, pancreatic, and breast cancer. Surveillance and regular screening are recommended to detect and treat any cancerous or pre-cancerous lesions at an early stage. The frequency and age at which screenings should be performed may vary based on individual risk factors, and genetic testing may be helpful in determining the appropriate screening and management strategies for each patient.

Research and Clinical Trials

– Researchers and clinicians are actively studying Peutz-Jeghers syndrome to better understand its pathogenesis, clinical presentation, and optimal management. Several ongoing studies and clinical trials are being conducted to investigate potential treatment options and improve patient outcomes.

– Various research centers, advocacy organizations, and databases such as the Peutz-Jeghers Syndrome Support Group, Gastroenterol and Phillips Center for Complex Inheritance, and OMIM Catalog of Human Genes and Genetic Diseases provide additional resources and support for individuals and families affected by Peutz-Jeghers syndrome.

– References to scientific articles on PubMed can be found for those interested in learning more about the scientific studies and advances related to Peutz-Jeghers syndrome and its associated conditions.

References

Genetic Home Reference. Peutz-Jeghers syndrome. Available at: https://ghr.nlm.nih.gov/condition/peutz-jeghers-syndrome. Accessed April 27, 2021.
Peutz-Jeghers Syndrome. NIH: Genetic and Rare Diseases Information Center. Available at: https://rarediseases.info.nih.gov/diseases/8368/peutz-jeghers-syndrome. Accessed April 27, 2021.
Phillips KA, et al. Peutz-Jeghers syndrome: Systematic review and recommendations for management. Gut. 2005;54(12):1615-1622.
McGarrity TJ, et al. Peutz-Jeghers syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993-2021. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1266/. Accessed April 27, 2021.
Beggs AD, et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59(7):975-986.
Giardiello FM, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2014;109(8):1159-1179.

Frequency

Causes

Learn more about the gene associated with Peutz-Jeghers syndrome

Inheritance

Other Names for This Condition

Additional Information Resources

Genetic Testing Information

Genetic and Rare Diseases Information Center

Patient Support and Advocacy Resources

Research Studies from ClinicalTrials.gov

Catalog of Genes and Diseases from OMIM

Scientific Articles on PubMed

Genetic Causes

Clinical Presentation

Cancerous Risks

Research and Clinical Trials

References

RECOMMENDED

CTNNB1 gene

HNRNPK gene

Schwartz-Jampel syndrome